Allergic contact dermatitis to pimecrolimus

被引：12
作者：
Saitta, Peter
Brancaccio, Ronald
机构：
[1] Univ Med & Dent New Jersey, Sch Osteopath Med, Stratford, NJ 08024 USA
[2] NYU, Sch Med, Ronald O Perelman Dept Dermatol, Brooklyn, NY 11209 USA
来源：
CONTACT DERMATITIS | 2007年 / 56卷 / 01期
关键词：
allergic contact dermatitis; Elidel (R); pimecrolimus;
D O I：
10.1111/j.1600-0536.2007.00822.x
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Pimecrolimus suppresses the proinflammatory cytokine production of cutaneous T and mast cells (1). It is used to treat atopic dermatitis and is the active ingredient in the topical formulation pimecrolimus 1.0% cream (Elidel (R), Novartis Pharma AG, Basel, Switzerland).
引用
收藏
页码：43 / U3
页数：2
相关论文
共 4 条
  • [1] Pimecrolimus cream 1%: A new development in nonsteroid topical treatment of inflammatory skin diseases
    Herbert, AA
    Warken, KA
    Cherill, R
    [J]. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2001, 20 (04) : 260 - 267
  • [2] Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants
    Ho, VC
    Gupta, A
    Kaufmann, R
    Todd, G
    Vanaclocha, F
    Takaoka, R
    Fölster-Holst, R
    Potter, P
    Marshall, K
    Thurston, M
    Bush, C
    Cherill, R
    [J]. JOURNAL OF PEDIATRICS, 2003, 142 (02) : 155 - 162
  • [3] Pimecrolimus cream in the long-term management of atopic dermatitis in adults:: A six-month study
    Meurer, M
    Fölster-Holst, R
    Wozel, G
    Weidinger, G
    Jünger, M
    Bräutigam, M
    [J]. DERMATOLOGY, 2002, 205 (03) : 271 - 277
  • [4] WAHN U, 2002, PEDIATRICS, V101, P158
1